Greenphire, a of payment technologies for the clinical trials industry, announced that the company's CEO, Sam Whitaker, has been selected as a finalist for the Ernst & Young Entrepreneur of the Year Awards 2013 in the Greater Philadelphia region.
The awards recognize entrepreneurs that create and build market-leading businesses, taking standards of excellence to new heights and helping to transform the face of their respective industries. Whitaker was chosen from over 70 executives as a finalist for his achievements in building Greenphire into an industry leader.
"I am delighted to have been selected as a finalist by Ernst & Young and to be honored along with fellow nominees,” Whitaker said. “As Greenphire grows and expands internationally, it is gratifying to be recognized for our successes in transforming outdated processes in the clinical trials industry. It would not have been possible without the tireless work of all the team members at Greenphire."
Since founding Greenphire, Whitaker has leveraged his entrepreneurial vision to simplify processes within clinical studies, replacing burdensome manual methods with platform-driven tools that execute complex payment processes globally. In five years he has built Greenphire from a two-person concept-driven start-up to an established player in the industry. The company now employs approximately 50 people on two continents.